| 7.93 Data as of May 23 |  +0.12 / +1.54%Today’s Change | 4.04 Today|||52-Week Range 11.24 | +31.95% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Lanphier Edward O Ii President & Chief Executive Officer |  Sale | 2/28/2013 | 25,000 | $10.00 | $250.0K | -22.18% |
Ando Dale G VP-Therapeutic Development & Chief Medical Officer | Sale | 4/26/2013 | 15,000 | $10.72 | $160.8K | -24.48% |
Ando Dale G VP-Therapeutic Development & Chief Medical Officer | Sale | 1/28/2013 | 15,000 | $9.68 | $145.2K | -18.58% |
Ando Dale G VP-Therapeutic Development & Chief Medical Officer | Sale | 3/26/2013 | 15,000 | $9.18 | $137.7K | -13.71% |
Ando Dale G VP-Therapeutic Development & Chief Medical Officer | Sale | 2/26/2013 | 15,000 | $8.64 | $129.6K | -9.58% |
Wolff Henry Ward Chief Financial Officer & Executive Vice President | Sale | 1/23/2013 | 10,000 | $10.00 | $100.0K | -19.16% |
Wolff Henry Ward Chief Financial Officer & Executive Vice President | Sale | 2/28/2013 | 10,000 | $10.00 | $100.0K | -22.18% |
Wolff Henry Ward Chief Financial Officer & Executive Vice President | Sale | 4/10/2013 | 10,000 | $10.00 | $100.0K | -21.64% |
Ando Dale G VP-Therapeutic Development & Chief Medical Officer | Sale | 12/26/2012 | 15,000 | $5.92 | $88.8K | +35.56% |
Ando Dale G VP-Therapeutic Development & Chief Medical Officer | Sale | 10/26/2012 | 15,000 | $5.69 | $85.4K | +41.35% |
.
